Trials / Sponsors / Reven Pharmaceuticals, Inc.
Reven Pharmaceuticals, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Tolerability and Efficacy of RJX in Patients With COVID-19 COVID-19, Acute Respiratory Distress Syndrome, SARS-CoV-2 | Phase 1 / Phase 2 | 2021-03-25 |
| Unknown | Revascularization of Stenosed Vessels Using Optimized Treatment of Rejuveinix for Reversing Endothelial Dysfun Critical Limb Ischemia, Peripheral Arterial Disease | Phase 1 / Phase 2 | 2020-01-01 |
| Completed | A Safety and Tolerability Study of RJX Drug Product in Healthy Participants Critical Limb Ischemia | Phase 1 | 2018-08-24 |